t-cell dysfunction in cll and implications for car-t
Published 2 years ago • 212 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:10
response to car t-cell treatment in cll patients
-
1:49
car-t cell approaches in cll: current progress & future directions
-
2:52
how cll cells suppress t-cell function
-
3:39
car t-cells in cll: the current landscape
-
1:09
car-t for cll
-
1:29
combining ibrutinib with car-t cells: a promising therapeutic strategy in cll
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:25
where are we with car-t in cll?
-
7:30
canon medical anz product & technology update 2021 - ct and hit
-
1:02:10
what is cll? - diagnosis and treatment
-
20:21
standard ct data processing with ltt
-
4:18
duvelisib in car t-cell therapy for cll
-
1:48
developing t-cell based therapies for cll treatment
-
1:46
overcoming t-cell dysfunction
-
2:04
the evolving role of car-t therapy in cll
-
1:56
the state of car t-cell products today
-
2:05
cll & car-t: the intricacies and potential
-
1:46
car-t as a next-generation therapy for cll
-
9:35
treatment-changing advancements in cll: btk, bcl-2, cd20 & car t-cells
-
2:19
car t-cell therapy updates in cll
-
2:55
car t-cell update: what’s new in dlbcl and mm?
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells